Skip to content

Effects of Whole Body Vibration in Different Devices on Bone and Muscle Mass in Postmenopausal Women

Effects of Whole Body Vibration in Different Devices on Bone and Muscle Mass, Physical Performance, Quality of Life and Falls in Postmenopausal Women

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06222931
Enrollment
228
Registered
2024-01-25
Start date
2024-01-15
Completion date
2025-06-30
Last updated
2024-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Density, Muscles, Physical Functional Performance, Accidental Falls, Quality of Life

Brief summary

Postmenopausal women suffer from a series of negative health factors, such as decreased bone and muscle mass and physical performance, increasing the risk of falls and decreasing quality of life. Therefore, intervention strategies aimed at mitigating these factors are essential. A technique that has been studied and can reverse these factors is whole-body vibration (WBV), however studies present contradictory results and the main confounding factor appears to be related to the type of vibration (synchronous or side-alternating). Therefore, the primary objective of this project is to verify the effects of 12 months of whole-body vibration on different devices on bone mineral density measurements in postmenopausal women. As a secondary objective, the effects on muscle mass, physical performance, quality of life and falls will be verified. 228 postmenopausal women will participate in the study and will be randomized to: triplanar vibration (synchronous); side-alternating vibration; or false vibration. The interventions will last 12 months and will occur three times a week on non-consecutive days. The following assessments will be carried out at baseline, 6-months and 12-months: bone mineral density and muscle mass by DXA equipment, muscle thickness by ultrasound, peak torque of the knee extensor and flexor muscles by an isokinetic dynamometer, hand grip, balance static postural and vertical jump on a force platform, dynamic balance using the Timed Up and Go test, SPPB battery, fear (FES-I) and incidence of falls and quality of life (SF-36).

Interventions

DEVICETriplanar vibrating platform

Mechanical vibration emitted by triplanar vibrating platforms

DEVICESide-alternating vibrating platform

Mechanical vibration emitted by side-alternating vibrating platforms

Simulated vibration

Sponsors

Conselho Nacional de Desenvolvimento Científico e Tecnológico
CollaboratorOTHER_GOV
Universidade Estadual do Norte do Parana
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
50 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Being postmenopausal (without menstruating for at least 12 months); * Not performing physical exercise systematically for at least 6 months; * Not needing assistance to carry out daily tasks; * Do not present serious cognitive problems that make it impossible to understand simple commands; * Do not have serious dysfunctions or implants in the spine, hips or lower limbs; * Not have neurological diseases or diseases that affect bone metabolism; * Do not have vascular diseases, arrhythmia, use a pacemaker, suffer from epilepsy or seizures; * No diseases/problems that affect the retina; * Do not present severe labyrinthitis or vertigo; * Not using medication/supplements to increase bone and/or muscle mass for at least 6 months; * Have not undergone cancer treatment in the last 5 years.

Exclusion criteria

* Withdraw from participating in the study for any reason; * Present adverse events during interventions that cannot be controlled.

Design outcomes

Primary

MeasureTime frameDescription
Bone mineral densityBaseline (pre-intervention), 6-months and 12-monthsBone mineral density of the lumbar spine, total hip, femoral neck and trochanter assessed by DXA, expressed in g/cm2
Appendicular skeletal muscle massBaseline (pre-intervention), 6-months and 12-monthsAppendicular skeletal muscle mass assessed by DXA, expressed in kg/m2

Secondary

MeasureTime frameDescription
Dynamic balanceBaseline (pre-intervention), 6-months and 12-monthsTimed Up and Go test: time taken to get up from a chair, walk three meters, return and sit down in the chair.
Hand grip strengthBaseline (pre-intervention), 6-months and 12-monthsHandgrip test using a Jamar hydraulic dynamometer, expressed in kg.
Static postural balanceBaseline (pre-intervention), 6-months and 12-monthsBipedal and semi-tandem postural balance test on a force platform to verify the antero-posterior displacement speed (cm/s), medio-lateral displacement speed (cm/s) and COP area (cm2).
Muscle thicknessBaseline (pre-intervention), 6-months and 12-monthsThickness of the rectus femoris muscle assessed by ultrasound, expressed in cm
Lower limb muscle strengthBaseline (pre-intervention), 6-months and 12-monthsPeak isokinetic torque (N.m) of the knee extensor and flexor muscles (concentric/concentric) evaluated by an isokinetic dynamometer at angular velocities of 60, 180 and 300º/s.
Fear of fallsBaseline (pre-intervention), 6-months and 12-monthsFear of falls assessed by the falls efficacy scale-international (FES-I), which generates scores from 16 to 64 points.
Health-related quality of lifeBaseline (pre-intervention), 6-months and 12-monthsThe SF-36 questionnaire will be used, which generates scores of 0-100 points for eight domains of health-related quality of life.
Muscle powerBaseline (pre-intervention), 6-months and 12-monthsCountermovement vertical jump with hands on waist to identify the power of the lower limbs expressed in watts.
Physical PerformanceBaseline (pre-intervention), 6-months and 12-monthsSPPB functional test battery composed of: static balance (feet together, semi-tandem, and full-tandem); gait speed test (4m); and 5-time sit-to-stand. All expressed in seconds.

Countries

Brazil

Contacts

Primary ContactRaphael G de Oliveira, PhD
rgoliveira@uenp.edu.br+55(43)99641-7628
Backup ContactLaís C de Oliveira, PhD
oliveiralc@uenp.edu.br+55(43)99613-7944

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026